Skip to main content
. Author manuscript; available in PMC: 2012 Jun 28.
Published in final edited form as: Small. 2011 Feb 8;7(5):625–633. doi: 10.1002/smll.201002291

Figure 5.

Figure 5

Validation of SERS NPs with explanted xenograft tumors: A) Representative spectra for A431 tumors labeled ex vivo with three different NP types: targeted (dots; via anti-EGFR affibody), targeted with competitive inhibition (solid), and untargeted (dashes; blank). Specific signals arise from the targeted NPs. B) Collections of spectra create Raman maps from whole tumors and signal quantitated in (C). Error bars represent the standard error and * indicates significance at p < 0.01.